Drug Type Small molecule drug |
Synonyms- |
Target |
Action modulators |
Mechanism TGR5 modulators(G-protein coupled bile acid receptor 1 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Asthma | Discovery | - | 01 Dec 2023 | |
| Asthma | Discovery | - | 01 Dec 2023 | |
| Cardiovascular Diseases | Discovery | - | 01 Dec 2023 | |
| Cardiovascular Diseases | Discovery | - | 01 Dec 2023 | |
| Connective Tissue Diseases | Discovery | - | 01 Dec 2023 | |
| Connective Tissue Diseases | Discovery | - | 01 Dec 2023 | |
| Digestive System Disorders | Discovery | - | 01 Dec 2023 | |
| Digestive System Disorders | Discovery | - | 01 Dec 2023 | |
| Endocrinology and Metabolic Disease | Discovery | - | 01 Dec 2023 | |
| Endocrinology and Metabolic Disease | Discovery | - | 01 Dec 2023 |





